
A Connecticut state agency is withdrawing from the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearings, owing to a lack of faith in the process amid administrative “shenanigans.”
The Connecticut Office of the Cannabis Ombudsman (OCO), along with My Doc App, which is a medical cannabis company that facilitates patient recommendations, submitted a notice of withdrawal to the DEA administrative law judge’s (ALJ) office on Thursday, simply stating that they “no longer wish to participate in these proceedings, and therefore, respectfully withdraw.”
While the DEA hearings on the proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) have been delayed, this latest development could further complicate the matter. Most designated participants selected for the hearings represented anti-rescheduling interests, and so this leaves even fewer voices supporting the reform.
“Though it was the honor of a lifetime and the culmination of a forty-year advocacy career to be named a Designated Participant, OCO has withdrawn from the DEA Cannabis Rescheduling proceedings,” Connecticut Cannabis Ombudsman Erin Kirk told Marijuana Moment on Friday.
“The behind-the-scenes shenanigans between the DEA and only certain parties caused us to lose faith in the process, and with our limited resources, it was
Read full article on Marijuana Moment